Vimac Ventures
VC Fund
Boston, United States
Vimac Ventures is a VC fund in Boston focused on Software and Advertising. VIMAC's investing model is founded on two core principles—respect for the entrepreneur, and humble acceptance that nobody has seen the future. New business creation is essentially a collaborative enterprise where success requires continuous learning and broad-based sharing of innovative ideas.Based in Boston, they deploy capital inearly-stage companies located in the eastern U.S. and Canada. Today, they have two separate investment teams—one focused on early stage ventures in IT/Adv.Materials technologies and the other focused on life sciences.To date, VIMAC investments have led to the creation of over 20 successful companies that continue to generate business innovations in IT, communications, and Internet technologies. These investments today account for over $2 billion in market value. The fund seeks to make about five new investments each year. A new investment typically goes into a Series A or Series B round with adequate reserves to support subsequent funding until the company exits via a trade sale or an IPO. Over its lifetime, a company is likely to receive $5 million to $15 million from the fund. The life sciences team makes investments from the VIMAC Milestone Medica in early stage biotechnology and medical device companies.They lead or co-lead most investments and their managers play a very active role on portfolio companies’ Boards of Directors. Often, they invest in a company's first institutional round of funding and maintain support throughout the company’s lifecycle. Along the way, they maintain a close working relationship with the management team, helping them refine business plan, build go-to-market strategies, enhance capital efficiency, find early customers and partners, and grow the business.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Vimac Ventures invests in
Stages Vimac Ventures invests in
Countries Vimac Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $3M–$6.8M
- Series B
- $3M–$10M
Investment Focus
Industry
- Software 8 (44%)
- Advertising 2 (11%)
- Manufacturing 2 (11%)
- Cyber Security 2 (11%)
- Enterprise Software 2 (11%)
Stage
- Series B 6 (33%)
- Series A 4 (22%)
- Funding Round 4 (22%)
- Series C 3 (17%)
- Series D 1 (6%)
Country
- United States 8 (44%)
- Canada 4 (22%)
- New Zealand 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Marcus
Managing Director, Life Sciences
|
Managing Director, Life Sciences | Total investments: 0 | Find email | |
Douglas G. Redding
Executive-in-Residence
|
Executive-in-Residence | Total investments: 0 | Find email | |
Keith W. Cooper
Executive-in-Residence
|
Executive-in-Residence | Total investments: 0 | Find email | |
R. Dana Ono, PhD
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Robert C. Roeper
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Combinent Biomedical Systems
|
Combinent Biomedical Systems, Inc., a women's healthcare company, offers multi-segmented vaginal rings that allow the delivery of hydrophobic and hydrophilic molecules, proteins, and other large molecules. It focuses on transvaginal delivery of drugs targeting women's reproductive endocrinology disorders, as well as diabetes, obesity, andinfectious diseases. Combinent Biomedical Systems, Inc. was incorporated in 2000 and is based in Lexington, Massachusetts. | $500K / Dec 17, 2009 | |
AeroSafe Global
|
AeroSafe Global develops and produces aerogels and related materials for temperature-sensitive shipping needs in the United States. Its products are used in various thermal insulation applications to transport biomedical, pharmaceutical, and other temperature-sensitive products. The company provides a reliable, simple, and sustainable temperaturesensitive supply chain solutions to the world’s leading biopharma companies.AeroSafe Global delivers cold-chain services for the biopharma industry that results in zero temperature excursions for every client, every product, every time. With proprietary packaging, logistics, and operational services, the company builds customized solutions that ensure the safe delivery of temperature-sensitive biopharmaceuticals. | $3.2M / Series B / Nov 28, 2007 | |
NeoEdge Networks
|
NeoEdge Networks is an in game advertising firm. | $3M / Series B / Jun 08, 2007 | |
Atlantis Components
|
Atlantis has designed a software system known as the Virtual Abutment Design (VAD) system. VAD allows their technicians to design abutments with a certainty and precision previously unknown to implant dentistry.The following is an overview of the Atlantis VAD and titanium machining process. The same process is followed by their technicians forsingle and multiple unit cases. | $9.8M / Series D / May 22, 2007 | |
|
Combinent Biomedical Systems
|
Combinent Biomedical Systems, Inc., a women's healthcare company, offers multi-segmented vaginal rings that allow the delivery of hydrophobic and hydrophilic molecules, proteins, and other large molecules. It focuses on transvaginal delivery of drugs targeting women's reproductive endocrinology disorders, as well as diabetes, obesity, andinfectious diseases. Combinent Biomedical Systems, Inc. was incorporated in 2000 and is based in Lexington, Massachusetts. | $3M / Series A / May 08, 2007 | |
Natural Convergence
|
Natural Convergence, Inc. supplies hosted voice over Internet protocol (VoIP) software for service providers supporting the small business market. The company develops and markets silhouette, a VoIP hosted software for telecom carriers and service providers. It offers services ranging from customizable training, professional services, projectmanagement, starter bundle selections, and a channel program. The company serves customers in Canada, the United States, the United Kingdom, the Netherlands, and the Caribbean. Natural Convergence, Inc. was founded in 2001 and is headquartered in Ottawa, Canada. | $10M / Series C / Nov 21, 2006 | |
Signiant
|
Signiant's enterprise software provides people and systems with fast, reliable, secure global access to valuable media assets ⎯ regardless of storage type or location. Its cloud-native Software Defined Content Exchange (SDCX) SaaS platform anchors the next-generation media technology stack, optimizing content flow within and between more than50,000 media companies of all sizes. From content creation through distribution, Signiant plays a mission-critical role in file-based workflows and cloud upload/download across the media supply chain. | $10M / Sep 13, 2006 | |
|
NeoEdge Networks
|
NeoEdge Networks is an in game advertising firm. | $5.5M / Series A / Jul 26, 2006 | |
GEOCOMtms
|
As of March 7, 2007, GEOCOMtms, Inc. was acquired by RedPrairie Corporation. GEOCOMtms, Inc. provides integrated fleet management software for local and short-haul pickup and delivery operations. It offers A.MAZE Fleet Management, which provides integrated software for route planning, trucking dispatch, GPS fleet tracking, mobile field service, andfleet maintenance. The company’s services include implementation, training, and support. It serves couriers, food and beverage, last mile delivery, logistics providers, petroleum, and retail distribution industries. The company was founded in 1999 and is based in Atlanta, Georgia. | $3.1M / Jun 16, 2005 | |
Nakina Systems
|
Nakina Systems provides Network Integrity Management solutions to the telecommunications industry worldwide. Our solutions enable service providers to introduce new services and grow networks more rapidly and with fewer outages by automating the discovery of network equipment, reconciling with inventory systems, auditing software in the network,and centralizing management of network security. Nakina's solutions power integrity in the world's largest networks, and they are provided in partnership with the world's largest and most advanced equipment manufacturers. | $10M / Series B / Apr 19, 2005 | |
| See all 18 investments → | |||
Co-Investors
BDC Venture Capital
3 deals together
Desjardins Venture Capital
3 deals together
Jefferson Partners
3 deals together
Primaxis Technology Ventures
3 deals together
Purple Angel
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Vimac Ventures invest in?
Vimac Ventures invests primarily in Software, Advertising and Manufacturing startups, most often at Series B and Series A stage. Most of the 18 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Vimac Ventures's check size?
Vimac Ventures typically joins rounds of $3M–$6.8M at Series A and $3M–$10M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Vimac Ventures participates in.
How do I contact Vimac Ventures?
Public channels for Vimac Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Vimac Ventures?
The team at Vimac Ventures includes David Marcus (Managing Director, Life Sciences), Douglas G. Redding (Executive-in-Residence) and Keith W. Cooper (Executive-in-Residence), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
